Khaled A. Ahmed
Depaltment of Molecular
Medicine,
Faculty of Medicine, University of Malaya,
50603 Kuala Lumpur, Malaysia
Sekaran Muniandy
Depaltment of Molecular
Medicine,
Faculty of Medicine, University of Malaya,
50603 Kuala Lumpur, Malaysia
Ikram S. Ismail
Endocrinology Unit, Department of Medicine, University of Malaya Medical Center, Universiw of Malaya, 50603 Kuala Lumpur, Malaysia
ABSTRACT
The aim of this study is to evaluate the role of the glycoxidation product, Nε-(carboxymethyl)lysine (CML), on the metabolism of LDL which can give rise to increased risks of Coronary Artery Disease (CAD) in Type 2 Diabetes Mellitus (T2DM) patients. Polyclonal anti-CML antibodies, were used for measurement of serum CML. CML concentrations were measured by competitive enzyme-linked immunosorbent assay (ELISA) in the serum of 81 T2DM patients with CAD, 86 T2DM without CAD and 104 healthy subjects. LDLs from the study groups were isolated and labeled with the fluorescence dye, 1, 1`-dioctadecyl-3, 3, 3`, 3`-tetramethylindo carbocyanine perchlorate (DiI). LDL from healthy subjects was subjected to oxidation and glycation. Receptor-mediated uptake of labeled native and modified-LDL was studied in human hepatocellular carcinoma (HepG2) cells. CML concentrations were significantly higher in T2DM with CAD patients than diabetic patients but without CAD (529.5±83.6 vs. 425.1±64.4 ng mL-1, p<0.001). The uptake of DiI-LDL from type 2 diabetes patients with CAD was significantly lower than that for LDL from diabetic patients without CAD or glycated-LDL in HepG2 cells. This study demonstrated that CML may be largely responsible for the defective uptake of LDL of T2DM with CAD. Thus, CML may be used as endogenous biomarker for early detection of CAD in type 2 diabetes patients and may be considered as a new goal for the glycemic control in those patients.
PDF References Citation
How to cite this article
Khaled A. Ahmed, Sekaran Muniandy and Ikram S. Ismail, 2008. Implications of Nε-(Carboxymethyl)lysine in Altered Metabolism of Low Density Lipoproteins in Patients with Type 2 Diabetes and Coronary Artery Disease. Journal of Medical Sciences, 8: 152-161.
DOI: 10.3923/jms.2008.152.161
URL: https://scialert.net/abstract/?doi=jms.2008.152.161
DOI: 10.3923/jms.2008.152.161
URL: https://scialert.net/abstract/?doi=jms.2008.152.161
REFERENCES
- Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc., 285: 2486-2497.
CrossRefPubMedDirect Link - Baynes, J.W. and S.R. Thorpe, 2000. Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med., 28: 1708-1716.
CrossRef - Berg, T.J., K. Dahl-Jorgensen, P.A. Torjesen and K.F. Hanssen, 1997. Increased serum levels of Advanced Glycation End products (AGEs) in children and adolescents with IDDM. Diabetes Care, 20: 1006-1008.
CrossRefDirect Link - Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254.
CrossRefPubMedDirect Link - Braunwald, E., 1997. Cardiovascular medicine at the turn of the millennium: Triumphs, concerns and opportunities. N. Engl. J. Med., 337: 1360-1369.
CrossRefDirect Link - Bucala, R., Z. Makita, G. Vega, S. Grundy, T. Koschinsky, A. Cerami and H. Vlassara, 1994. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA., 91: 9441-9445.
Direct Link - Chung, B.H., J.P. Segrest, M.J. Ray, J.D. Brunzell and J.E. Hokanson et al., 1986. Single vertical spin density gradient ultracentrifugation. Methods Enzymol., 128: 181-209.
CrossRefDirect Link - Creager, M.A., T.F. Luscher, F. Cosentino and J.A. Beckman, 2003. Diabetes and vascular disease: Pathophysiology, clinical consequences and medical therapy: Part I. Circulation, 108: 1527-1532.
CrossRefDirect Link - Dashti, N., G. Wolfbauer, E. Koren, B. Knowles and P. Alaupovic, 1984. Catabolism of human low density lipoproteins by human hepatoma cell line HepG2. Biochim. Biophys. Acta (BBA)-Lipids Lipid Metab., 794: 373-384.
CrossRefDirect Link - Esterbauer, H., G. Striegl, H. Puhl and M. Rotheneder, 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun., 6: 67-75.
CrossRefDirect Link - Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
CrossRefPubMedDirect Link - Fu, M.X., J.R. Requena, A.J. Jenkins, T.J. Lyons, J.W. Baynes and S.R. Thorpe, 1996. The advanced glycation end product, Nε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem., 271: 9982-9986.
PubMedDirect Link - Galle, J., R. Schneider, B. Winner, C. Lehmann-Bodem and R. Schinzel et al., 1998. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress. Atherosclerosis, 138: 65-77.
CrossRefDirect Link - Ghosh, R.N. and W.W. Webb, 1994. Automated detection and tracking of individual and clustered cell surface low density lipoprotein receptor molecules. Biophys. J., 66: 1301-1318.
CrossRefDirect Link - Haffner, S.M., S. Lehto, T. Ronnemaa, K. Pyorala and M. Laakso, 1998. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med., 339: 229-234.
Direct Link - Hirata, K. and K. Kubo, 2004. Relationship between blood levels of N -(carboxymethyl)lysine and pentosidine and the severity of microangiopathy in type 2 diabetes. Endocr. J., 51: 537-544.
Direct Link - Ikeda, K., T. Higash, H. Sano, Y. Jinnouchi and M. Yoshida et al., 1996. Nε-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry, 35: 8075-8083.
CrossRefDirect Link - Imanaga, Y., N. Sakata, S. Takebayashi, A. Matsunaga and J. Sasaki et al., 2000. In vivo and In vivo evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Atherosclerosis, 150: 343-355.
Direct Link - Kawamura, M., J.W. Heinecke and A. Chait, 1994. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J. Clin. Invest., 94: 771-778.
CrossRefDirect Link - Kilhovd, B.K., T.J. Berg, K.I. Birkeland, P. Thorsby and K.F. Hanssen, 1999. Serum levels of advanced glycation end products are increased in patients with Type 2 diabetes and coronary heart disease. Diabetes Care, 22: 1543-1548.
CrossRefDirect Link - Kiuchi, K., J. Nejima, T. Takano, M. Ohta and H. Hashimoto, 2001. Increased serum concentrations of advanced glycation end products: A marker of coronary artery disease activity in type 2 diabetic patients. Heart, 85: 87-91.
Direct Link - Kuusisto, J., L. Mykkanen, K. Pyorala and M. Laakso, 1994. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes, 43: 960-967.
CrossRefDirect Link - Laakso, M., 1999. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes, 48: 937-942.
CrossRefDirect Link - Lamarche, B., J.P. Despres, S. Moorjani, B. Cantin, G.R. Dagenais and P.J. Lupien, 1995. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec cardiovascular study). Am. J. Cardiol., 75: 1189-1195.
CrossRefDirect Link - Miura, J., S. Yamagishi, Y. Uchigata, M. Takeuchi, H. Yamamoto, Z. Makita and Y. Iwamoto, 2003. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes. J. Diabetes Complications, 17: 16-21.
Direct Link - Moro, E., P. Alessandrini, C. Zambon, S. Pianetti, M. Pais, G. Cazzolato and G. Bittolo Bon, 1999. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre‐oxidative condition? Diabetes Med., 16: 663-669.
CrossRefDirect Link - Noble, R.P., 1968. Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res., 9: 693-700.
Direct Link - Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
CrossRefPubMedDirect Link - Posch, K., S. Simecek, T.C. Wascher, G. Jurgens, S. Baumgartner-Parzer, G.M. Kostner and W.F. Graier, 1999. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes, 48: 1331-1337.
CrossRefDirect Link - Requena, J.R., M.X. Fu, M.U. Ahmed, A.J. Jenkins, T.J. Lyons and S.R. Thorpe, 1996. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant., 11: 48-53.
CrossRefDirect Link - Sakata, N., N. Uesugi, S. Takebayashi, R. Nagai and T. Jono et al., 2001. Glycoxidation and lipid peroxidation of low density lipoprotein can synergistically enhance atherogenesis. Cardiovasc. Res., 49: 466-475.
Direct Link - Sakurai, T., S. Kimura, M. Nakano and H. Kimura, 1991. Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem. Biophys. Res. Commun., 177: 433-439.
CrossRefDirect Link - Sampathkumar, R., M. Balasubramanyam, M. Rema, C. Premanand and V. Mohan, 2005. A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism, 54: 1002-1007.
Direct Link - Schleicher, E., T. Deufel and O.H. Wieland, 1981. Non-enzymatic glycosylation of human serum lipoproteins elevated ϵ-lysine glycosylated low density lipoprotein in diabetic patients. FEBS. Lett., 129: 1-1.
CrossRefDirect Link - Schleicher, E.D., E. Wagner and A.G. Nerlich, 1997. Increased accumulation of the glycoxidation product N -(carboxymethyl)lysine in human tissues in diabetes and ageing. J. Clin. Invest., 99: 457-468.
PubMed - Schmidt, A.M., S.D. Yan, J. Brett, R. Mora, R. Nowygrod and D. Stern, 1993. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J. Clin. Invest., 91: 2155-2168.
CrossRefDirect Link - Stephan, Z.F. and E.C. Yurachek, 1993. . Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J. Lipid Res., 34: 325-330.
Direct Link - Teupser, D., J. Thiery, A.K. Walli and D. Seidel, 1996. Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim. Biophys. Acta-Lipids Lipid Metab., 1303: 193-198.
CrossRefDirect Link - Wautier, M.P., P. Massin, P.J. Guillausseau, M. Huijberts and B. Levy et al., 2003. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab., 29: 44-52.
CrossRefDirect Link